Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-02-25 Sale |
2021-03-01 4:08 pm |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
24,000 | $22.06 | $529,440 | 228,352 (Direct) |
View |
2021-02-18 Sale |
2021-02-19 4:12 pm |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
1,808 | $19.15 | $34,623 | 40,839 (Direct) |
View |
2021-01-08 Sale |
2021-01-12 4:08 pm |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
65,000 | $20 | $1,300,000 | 609,099 (Direct) |
View |
2020-12-30 Sale |
2020-12-31 4:06 pm |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
1,733 | $17.48 | $30,293 | 26,029 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 5:33 pm |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP, Clinical&Translational Sc |
371 | $17.81 | $6,608 | 63,240 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 4:09 pm |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
567 | $17.81 | $10,098 | 27,762 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 12:53 pm |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
916 | $17.81 | $16,314 | 248,345 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 11:56 am |
Axogen Inc. | AXGN | MARIANI PETER J Chief Financial Officer |
1,293 | $17.81 | $23,028 | 10,376 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 11:55 am |
Axogen Inc. | AXGN | Scopelianos Angelo VP Research & Development |
567 | $17.81 | $10,098 | 5,529 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 11:53 am |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
3,500 | $17.81 | $62,335 | 674,099 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 11:52 am |
Axogen Inc. | AXGN | Friedman Mark Louis VP,Regulatory & Quality |
567 | $17.81 | $10,098 | 11,124 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 11:51 am |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
567 | $17.81 | $10,098 | 4,665 (Direct) |
View |
2020-12-29 Sale |
2020-12-30 11:51 am |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
649 | $17.81 | $11,559 | 9,496 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-06-01 Exercise |
2021-06-03 5:11 pm |
N/A N/A |
Axogen Inc. | AXGN | Levine Alan M Director |
6,173 | $0 | 17,830 (Direct) |
View |
2021-06-01 Option Award |
2021-06-03 5:11 pm |
N/A 2031-06-01 |
Axogen Inc. | AXGN | Levine Alan M Director |
9,066 | $0 | 17,830 (Direct) |
View |
2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2026-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
50,000 | $8.95 | 331,306 (Direct) |
View |
2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2023-05-26 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
21,000 | $5.45 | 331,306 (Direct) |
View |
2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2021-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
22,954 | $3.67 | 331,306 (Direct) |
View |
2021-05-26 Exercise |
2021-05-28 4:05 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
9,000 | $5.09 | 331,306 (Direct) |
View |
2021-05-19 Exercise |
2021-05-21 4:21 pm |
N/A 2022-08-26 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
25,000 | $3.8 | 42,591 (Direct) |
View |
2021-05-19 Exercise |
2021-05-21 4:21 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | NEELS GUIDO J Director |
15,000 | $5.09 | 42,591 (Direct) |
View |
2021-04-28 Exercise |
2021-04-30 4:10 pm |
2015-05-01 2021-05-01 |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP of Clin. & Trans. Sciences |
10,000 | $2.86 | 78,082 (Direct) |
View |
2021-04-16 Exercise |
2021-04-20 4:09 pm |
N/A 2022-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
100,000 | $5.09 | 875,912 (Direct) |
View |
2021-03-25 Exercise |
2021-03-29 4:17 pm |
2015-12-29 2021-12-29 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
69,000 | $3.67 | 665,912 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:56 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Friedman Mark Louis VP Regulatory Affairs & Policy |
35,300 | $0 | 35,300 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:56 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
35,300 | $0 | 35,300 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:55 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
48,400 | $0 | 60,200 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:55 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
35,300 | $0 | 35,300 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:55 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP, Clinical&Translational Sc |
35,300 | $0 | 35,300 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:54 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
126,600 | $0 | 126,600 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:54 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Ottinger Bradley General Counsel and CCO |
42,990 | $0 | 54,790 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:53 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Sandberg Eric Chief Commercial Officer |
35,300 | $0 | 35,300 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:53 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | MARIANI PETER J EVP & Chief Financial Officer |
91,500 | $0 | 91,500 (Direct) |
View |
2021-03-16 Option Award |
2021-03-18 5:53 pm |
N/A 2031-03-16 |
Axogen Inc. | AXGN | Scopelianos Angelo Chief R&D Officer |
50,500 | $0 | 50,500 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:27 pm |
N/A N/A |
Axogen Inc. | AXGN | Scopelianos Angelo Chief R&D Officer |
1,325 | $0 | 7,046 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:27 pm |
N/A N/A |
Axogen Inc. | AXGN | Scopelianos Angelo Chief R&D Officer |
406 | $18.71 | 7,046 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:26 pm |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP, Regulatory & Quality |
590 | $18.7 | 13,936 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:26 pm |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP, Regulatory & Quality |
3,111 | $0 | 13,936 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:26 pm |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP, Regulatory & Quality |
361 | $18.71 | 13,936 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:26 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP, Clinical&Translational Sc |
1,864 | $18.7 | 68,082 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:26 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP, Clinical&Translational Sc |
6,231 | $0 | 68,082 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:25 pm |
N/A N/A |
Axogen Inc. | AXGN | Sandberg Eric Chief Commercial Officer |
903 | $18.7 | 3,223 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:25 pm |
N/A N/A |
Axogen Inc. | AXGN | Sandberg Eric Chief Commercial Officer |
2,531 | $0 | 3,223 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:17 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
2,605 | $0 | 42,647 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:17 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
797 | $18.71 | 42,647 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:16 pm |
N/A N/A |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
1,577 | $18.7 | 252,352 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:16 pm |
N/A N/A |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
5,161 | $0 | 252,352 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
1,325 | $0 | 5,584 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
406 | $18.71 | 5,584 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J Chief Financial Officer |
789 | $18.7 | 18,234 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J Chief Financial Officer |
10,812 | $0 | 18,234 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J Chief Financial Officer |
2,165 | $18.71 | 18,234 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
29,999 | $0 | 631,412 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:15 pm |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
7,686 | $18.71 | 631,412 (Direct) |
View |
2021-02-16 Option Award |
2021-02-18 5:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
1,325 | $0 | 11,080 (Direct) |
View |
2021-02-17 Tax Withholding |
2021-02-18 5:14 pm |
N/A N/A |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
454 | $18.71 | 11,080 (Direct) |
View |
2021-02-05 Tax Withholding |
2021-02-09 7:12 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
5,190 | $19.81 | 40,839 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:12 pm |
N/A 2022-09-22 |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
20,000 | $0 | 40,839 (Direct) |
View |
2021-02-05 Exercise |
2021-02-09 7:12 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
20,000 | $5.14 | 40,839 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 5:33 pm |
N/A N/A |
Axogen Inc. | AXGN | DeVinney Erick Wayne VP, Clinical&Translational Sc |
1,500 | $0 | 63,240 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 4:09 pm |
N/A N/A |
Axogen Inc. | AXGN | Donovan Michael Patrick VP Operations |
2,300 | $0 | 27,762 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 12:53 pm |
N/A N/A |
Axogen Inc. | AXGN | Freitag Gregory Gene Director |
2,300 | $0 | 248,345 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 11:56 am |
N/A N/A |
Axogen Inc. | AXGN | MARIANI PETER J Chief Financial Officer |
5,250 | $0 | 10,376 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 11:55 am |
N/A N/A |
Axogen Inc. | AXGN | Scopelianos Angelo VP Research & Development |
2,300 | $0 | 5,529 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 11:53 am |
N/A N/A |
Axogen Inc. | AXGN | Zaderej Karen L. CEO |
8,800 | $0 | 674,099 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 11:52 am |
N/A N/A |
Axogen Inc. | AXGN | Friedman Mark Louis VP,Regulatory & Quality |
2,300 | $0 | 11,124 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 11:51 am |
N/A N/A |
Axogen Inc. | AXGN | MARTINEZ MARIA D. Chief Human Resources Officer |
2,300 | $0 | 4,665 (Direct) |
View |
2020-12-27 Option Award |
2020-12-30 11:51 am |
N/A N/A |
Axogen Inc. | AXGN | Billet Isabelle Chief Strategy and BD Officer |
2,300 | $0 | 9,496 (Direct) |
View |